LYON, France
Poxel is a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH)
BioTech
Technologies
Life Science
Business model
B2B
Présence
France
N° Immat:
259 AVENUE JEAN JAURES
Secteurs cibles
Métiers cibles
Partenariat(s) recherché(s)
Partenaires